2004 Annual Meeting | Therapy of Pediatric Genetic Neurological Disorders

��ɫ��

2004 Annual Meeting | Therapy of Pediatric Genetic Neurological Disorders

Date Monday 04/26/04

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Dinner Seminar

Director(s) E. S. Roach, MD, FAAN

Topic(s) Neurogenetics/Neurometabolic Disorders/Neurotoxicology

Learning Objectives Upon completion:
Participants should be able to know the general approaches to treatment of genetic disorders affecting the nervous system; recognize the clinical features of selected genetic disorders for which treatment is available; and know the treatment of various genetic neurological disorders.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
06:30 PM - 06:40 PM		Introduction
06:40 PM - 07:30 PM		Molecular Mechanisms of Treatable Genetic Disorders Keith Hyland, PhD
07:30 PM - 08:20 PM		Dietary and Nutrient Therapy E. S. Roach, MD, FAAN
08:20 PM - 09:10 PM		Gene and Gene Product Replacement Michael M. Dowling, MD, PhD, FAAN
09:10 PM - 09:30 PM		Questions and Answers

Faculty Disclosures
E. S. Roach, MD, FAAN	No disclosure on file
Keith Hyland, PhD	No disclosure on file
Michael M. Dowling, MD, PhD, FAAN	Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Dowling has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NHLBI. The institution of Dr. Dowling has received research support from NIH.
	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��